NICOLE MCNEES: Open Payments
NPI 1528640364 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$320 in 17 payments from 11 companies in 2025. Trend: 2023 $145 · 2024 $299 · 2025 $320
Food & beverage: $320
| Company | Payments | Amount |
|---|---|---|
| CSL Behring | 5 | $104 |
| GlaxoSmithKline, LLC. | 2 | $38 |
| ABBVIE INC. | 2 | $36 |
| Gilead Sciences, Inc. | 1 | $28 |
| SHIELD THERAPEUTICS INC | 1 | $19 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $15 |
| Novo Nordisk Inc | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Andembry, TRELEGY ELLIPTA, VRAYLAR, Haegarda, ACCRUFER, GVOKE HYPOPEN, Kerendia, Auvelity.
Industry payments across KY — which companies pay providers there.
